Cargando…
TXNIP mediates the differential responses of A549 cells to sodium butyrate and sodium 4‐phenylbutyrate treatment
Sodium butyrate (NaBu) and sodium 4‐phenylbutyrate (4PBA) have promising futures in cancer treatment; however, their underlying molecular mechanisms are not clearly understood. Here, we show A549 cell death induced by NaBu and 4PBA are not the same. NaBu treatment induces a significantly higher leve...
Autores principales: | Jin, Xuefang, Wu, Nana, Dai, Juji, Li, Qiuxia, Xiao, XiaoQiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313639/ https://www.ncbi.nlm.nih.gov/pubmed/28033672 http://dx.doi.org/10.1002/cam4.977 |
Ejemplares similares
-
Sodium butyrate‐activated TRAF6‐TXNIP pathway affects A549 cells proliferation and migration
por: Xiao, Xiaoqiang, et al.
Publicado: (2019) -
Effect of sodium 4-phenylbutyrate on Clenbuterol-mediated muscle growth
por: Brown, David M., et al.
Publicado: (2018) -
Clinical and Experimental Applications of Sodium Phenylbutyrate
por: Iannitti, Tommaso, et al.
Publicado: (2012) -
A Patient with MSUD: Acute Management with Sodium Phenylacetate/Sodium Benzoate and Sodium Phenylbutyrate
por: Köse, Melis, et al.
Publicado: (2017) -
Sodium 4-phenylbutyrate suppresses the development of dextran sulfate sodium-induced colitis in mice
por: ONO, KAZUHIKO, et al.
Publicado: (2014)